PRMT5 is a therapeutic target in choroidal neovascularization.
Muniyandi A, Martin M, Sishtla K, Motolani A, Sun M, Jensen NR, Qi X, Boulton ME, Prabhu L, Lu T, Corson TW.
Muniyandi A, et al. Among authors: corson tw.
Sci Rep. 2023 Jan 31;13(1):1747. doi: 10.1038/s41598-023-28215-w.
Sci Rep. 2023.
PMID: 36720900
Free PMC article.